Abstract
#Glioblastoma (GBM- GIV astrocytoma) represents the most noted
neoplasms of the brain usually reported with dismal prognosis. The term
glioblastoma with #oligodendroglial component (GBMO) represents the
present of oligodendroglial foci in glioblastoma tumors. GBMOs are
usually represented with better therapeutic response and concomitant
prognostic outcome. We have observed nearly 610 cases of various
#pathologic grades of #astrocytoma from 2009 to 2014 and found the
oligodendroglial component among the 40 cases. Nearly in all the cases
of GBM and GBMOs received complete resection and was followed by
standard therapeutic regime of radiotherapy and chemotherapy with
#temozolomide. The survival pattern was observed in patients diagnosed
with GBM and GBMO. We have looked for the presence of MIB1, p53 and
necrosis pattern in selected GBMO sub group. We observe nearly 54% of
GBMOs stained positive with p53.#Necrosis and MIB1 was observed in most of the GBMO cases. These was
statistically significant difference among survival of glioblastoma
patients' and GBMOs.
For more articles on BJSTR Journal please click on https://biomedres.us/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.